REMEGEN CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.5 HKD | -4.67% |
|
-6.49% | -34.58% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 39,166 | 31,092 | 36,877 | 28,299 | 19,502 | - | - |
| Enterprise Value (EV) 1 | 36,595 | 29,387 | 34,808 | 28,741 | 21,026 | 21,332 | 21,722 |
| P/E ratio | -56.1 x | 111 x | -27.2 x | -12.2 x | -9.63 x | -16.5 x | -60.9 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 21.8 x | 48 x | 26.1 x | 11.8 x | 7.79 x | 5.69 x |
| EV / Revenue | - | 20.6 x | 45.3 x | 26.5 x | 12.7 x | 8.52 x | 6.34 x |
| EV / EBITDA | -60.4 x | 80.3 x | -43.8 x | -21.7 x | -21 x | -43.6 x | 160 x |
| EV / FCF | -33.2 x | -83.6 x | -17.2 x | -12.2 x | -15.8 x | -26.4 x | -90.9 x |
| FCF Yield | -3.02% | -1.2% | -5.8% | -8.2% | -6.35% | -3.79% | -1.1% |
| Price to Book | 10.9 x | 8.98 x | 3.64 x | 5.34 x | 4.17 x | 5.03 x | 5.52 x |
| Nbr of stocks (in thousands) | 489,837 | 489,837 | 539,197 | 538,532 | 537,914 | - | - |
| Reference price 2 | 79.96 | 63.47 | 51.14 | 34.04 | 22.80 | 22.80 | 22.80 |
| Announcement Date | 21-03-26 | 22-02-20 | 23-02-27 | 24-02-23 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 1,426 | 767.8 | 1,083 | 1,653 | 2,503 | 3,427 |
| EBITDA 1 | - | -605.6 | 365.8 | -794.1 | -1,322 | -1,000 | -489.2 | 135.5 |
| EBIT 1 | - | -668.6 | 281.6 | -980.9 | -1,502 | -1,167 | -513.8 | 11.95 |
| Operating Margin | - | - | 19.74% | -127.76% | -138.65% | -70.63% | -20.53% | 0.35% |
| Earnings before Tax (EBT) 1 | - | -697.8 | 276.3 | -998.8 | -1,511 | -1,289 | -760.4 | -215.1 |
| Net income 1 | -430.3 | -697.8 | 276.3 | -998.8 | -1,511 | -1,284 | -756.2 | -211.7 |
| Net margin | - | - | 19.37% | -130.09% | -139.55% | -77.71% | -30.21% | -6.18% |
| EPS 2 | - | -1.425 | 0.5700 | -1.880 | -2.799 | -2.367 | -1.384 | -0.3743 |
| Free Cash Flow 1 | - | -1,104 | -351.4 | -2,019 | -2,356 | -1,335 | -807.6 | -239 |
| FCF margin | - | - | -24.64% | -263% | -217.51% | -80.77% | -32.27% | -6.97% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 20-10-28 | 21-03-26 | 22-02-20 | 23-02-27 | 24-02-23 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 S1 | 2021 S2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q4 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,397 | - | - | 198.1 | 419 | - | 306.7 | 657.1 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | 720.3 | - | - | - | -509.7 | - | -480.6 | -807.9 |
| Net income 1 | -444 | - | -489.1 | -199.1 | - | -509.7 | -323.8 | -480.6 | -807.9 |
| Net margin | - | - | - | - | - | -121.65% | - | -156.74% | -122.95% |
| EPS | -0.9100 | - | -0.9600 | -0.3600 | - | - | -0.6000 | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 21-08-23 | 22-02-20 | 22-08-30 | 22-10-27 | 23-02-27 | 23-02-27 | 23-04-27 | 24-02-23 | 24-02-23 |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 442 | 1,525 | 1,831 | 2,220 |
| Net Cash position 1 | - | 2,571 | 1,704 | 2,069 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.3342 x | -1.524 x | -3.742 x | 16.38 x |
| Free Cash Flow 1 | - | -1,104 | -351 | -2,019 | -2,356 | -1,335 | -808 | -239 |
| ROE (net income / shareholders' equity) | - | -41.5% | 7.85% | -23.7% | -35.5% | -43.5% | -36.5% | -17% |
| ROA (Net income/ Total Assets) | - | -29% | 6.68% | -19.6% | -26.2% | -23.2% | -14.6% | -6.47% |
| Assets 1 | - | 2,403 | 4,138 | 5,090 | 5,775 | 5,546 | 5,167 | 3,271 |
| Book Value Per Share 2 | - | 7.340 | 7.070 | 14.00 | 6.380 | 5.470 | 4.530 | 4.130 |
| Cash Flow per Share 2 | - | -1.620 | 0.5400 | -2.380 | -2.780 | -1.430 | -0.8600 | 0.4800 |
| Capex 1 | - | 443 | 615 | 756 | 853 | 479 | 361 | 278 |
| Capex / Sales | - | - | 43.12% | 98.41% | 78.74% | 29% | 14.44% | 8.11% |
| Announcement Date | 20-10-28 | 21-03-26 | 22-02-20 | 23-02-27 | 24-02-23 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
22.8
CNY
Average target price
37.15
CNY
Spread / Average Target
+62.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -34.58% | 2.68B | |
| +15.20% | 121B | |
| +19.67% | 113B | |
| +18.95% | 26.02B | |
| -23.86% | 19.39B | |
| -19.03% | 15.91B | |
| -20.90% | 15.09B | |
| -46.14% | 15.06B | |
| +63.85% | 14.93B | |
| +4.49% | 13.85B |
- Stock Market
- Equities
- 9995 Stock
- Financials RemeGen Co., Ltd.
